The literature concerning various serological reactions in malaria in man has been well reviewed (1) . According to-this review, attempts to obtain a specific complement fixation reaction with sera from human beings infected by Plasmodium vivax or by Plasmodium falciparum have led in the past to inconclusive results because no sensitive, specific, and easily standardized antigen was available. Due to the difficulty in obtaining sufficient quantities of heavily infected human blood from which to prepare an antigen, these investigators developed an antigen from Plasmodium knowlesi which occurs naturally in the malaria of monkeys and can be used to induce malaria in man. A complement fixation test using such an antigen was found to give a group reaction with sera from human beings infected with Plasmodium vivax and Plasmodium falciparum.
When the onset of war made procurement of monkeys impracticable, two workers (2) prepared an antigen from the chicken malarial parasite Plasmodium gallinaceum. One of them (3) demonstrated the group specificity of this antigen, using the sera of soldiers with malaria at Percy Jones General Hospital. Further studies appeared desirable since there are no certain clinical criteria indicative of a complete cure in malaria and a test that could detect latent malaria would obviously serve a very useful purpose.
The present report deals with the serological investigations conducted at the Harmon General Hospital. The antigen prepared from Plasmodium gallinaceum was supplied originally by the aforementioned workers and subsequently by the Army Medical School. The specificity and sensitivity of this complement fixation test was studied iLt. Colonel, MC, A. U. S. 2Major, MC, A. U. S. 8 Captain, SnC, A. U. S. 4Colonel, MC, A. U. S. on 11,367 sera. These sera were obtained from 1000 normal healthy soldiers, from 95 soldiers with febrile illnesses other than malaria, from 481 men with syphilis, and from 505 soldiers who gave a history of malarial infection while in the South Pacific. During the period of study of the lastnamed group, there were 434 recurrent attacks of malaria due to Plasmodium vivax.
MATERIALS AND METHODS
Sera. One thousand sera for controls were obtained from normal healthy soldiers. None of these men had been overseas or had a history of malaria. Four hundred and seventy-five sera were obtained from 95 soldiers who likewise had never been overseas or had malaria but who were suffering from a febrile illness in which the body temperature was not less than 1000 F. at the time of drawing the initial blood sample. From each of these 95 patients, sera were taken for 5 consecutive days. Sera were taken from 481 men with syphilis who had never been overseas. These men were negro soldiers from various parts of the country and it is possible that some from the South may have had malaria contracted in the past. From the 505 patients with a history of malaria contracted in the South Pacific, sera were obtained at 5-day intervals and, when a recurrent attack of malaria developed, sera were taken on the day of onset and on each of the next 4 days. The taking of sera at 5-day intervals was then resumed. Smears. A thick or thin blood smear was made from capillary blood each time that serum was obtained by venepuncture. Staining was done by the Giemsa technique. The species of plasmodium was determined in each instance with special reference to the possibility of mixed infections.
Treatment. Acute malarial attacks were treated with atabrine, 2.8 grams in 7 days, for 50 per cent of the attacks; atabrine, 2.8 grams in 7 days followed by atabrine 0.1 gram daily for 60 days, in an additional 31 per cent; quinine, 16 grams in 7 days, in 3 per cent of attacks; quinine, 6 .0 grams in 2 days followed by atabrine 1.5 grams in 5 days followed by plasmochin 0.15 gram in 5 days, in 3 per cent; and various other combinations of these drugs in 5 per cent of attacks. The tubes were then incubated in the water bath for 30 minutes at 370 C. and read. The smallest amount of amboceptor giving complete hemolysis was taken as 1 unit. In the final test, there were 2 units contained in a volume of 0.25 ml. The amboceptor dilution containing 2 units remained constant for each lot, provided that the red blood corpuscles were prepared properly.
2. Complement titrations Complement was titrated each day that the tests were run. A series of tubes was set up containing 1: 10 complement as follows: The tubes were incubated for 30 minutes at 370 C. and read. The exact unit of complement was taken as the amount showing complete or almost complete hemolysis. For the final test two units of complement were used.
Preparation of antigen
The lyophilized antigen was restored to original volume with distilled water and then diluted 1: 10 with saline. The antigen was shaken thoroughly and then allowed to stand to get rid of the larger particles. The turbid supernatant fluid was pipetted off and serial dilutions of the antigen from 1: 10 through 1: 320 were prepared.
A series of two rows of tubes, A and B, containing the following were set up: The tubes were incubated in the water bath at 37°C. for 1 hour, after which 0.5 ml. of sensitized sheep red blood corpuscles were added. The tubes were then replaced in the water bath at 37°C. until the majority of tubes in row "B" showed complete hemolysis. The dilution of antigen showing complete fixation and no anticomplementary activity -was selected as the end-point.
It was found that the antigen unit invariably coincided with that given on the container. Quantitative titrations were performed on all sera that had given a 4+ reaction. In addition to repeating the test on these sera, the following dilutions were prepared: 1:5, 1:10, 1:15, 1:20, 1:30, 1:440, 1:60, 1:80, 1:120, and 1: 160. Normal, undiluted sera and sera diluted 1: 5 and 1: 10, were included in these titrations as controls. After the dilutions had been prepared the tests were performed in the same manner as above.
After approximately 3000 tests had been run, a modification in technique was introduced. With this procedure, the 0.85 per cent NaCl was buffered with 0.005 M phosphate (pH 7.2 to 7.4). The reagents were prepared in the same manner but the volume of each was adjusted so that it was contained in 0.2 ml. and the total volume for each test was 1 ml.
After the reagents were added, the tests were shaken and placed in the refrigerator at 50 C. overnight. The next morning there was added to each tube 0.2 ml. of 2 per cent sheep's corpuscle suspension sensitized with 2 units of amboceptor, making a total volume of 0.4 ml. The tubes were incubated at 370 C. for 30 minutes and then read. The activity of the hemolytic system was tested by refrigeration of the controls overnight followed by addition of the indicator series the following morning.
More than 8000 tests were performed using the icebox fixation method. At one time, because of the larger number of negative tests, it was thought that even though the complement unit was determined by titration, an excess was possibly being used. Therefore, duplicate tests were set up on the same sera using the complement unit as determined by titration for one series and a two-thirds unit of complement in the other series. This gave a larger number of positive results but also increased the number of anticomplementary results. Recently, we had the opportunity of comparing a large number ,of tests in duplicate using the old method and one recently introduced by Major C. H. Rein and Captain S. Bukantz (5) . The Figure 2 . Complement fixation during the recurrent attack. Sera were drawn for 5 consecutive days during recurrent attacks beginning at the time a smear was found to be positive. performed at 5-day intervals, exclusive of the periods of recurrent attacks (5 days). The purpose of the compilation is to demonstrate persistence or disappearance of positive complement fixation in patients with recurrent attacks and in those in whom subsequent attacks did not occur during this period of observation and serological investigation. One patient had 4 attacks but during the symptom-free intervals had 70 per cent negative tests. Seventeen patients had 3 attacks with 60 per cent negative tests in the intervals. Forty-two patients with 2 attacks had 64 per cent negative tests. Thirty-five patients with 1 attack had 72 per cent negative tests. Twenty-six patients with no attacks while in the hospital had 81 per cent negative tests. During their period of observation, these 26 patients had no definite clinical attacks of malaria or parasitemia. Of these, 1 had an attack of unobserved illness, which was probably malaria, 5 at no time complained of symptoms suggesting malaria, and 20 complained irregularly of varying aches or malaise which might have represented subclinical activity. Since, for the most part, these men resided in rehabilitation barracks where routine taking of temperature was purposely omitted, data were not collected which would permit a precise estimate of the relation of occasional rises in complement fixation (19 per cent positive tests) to subclinical activity. If the tests of the first 3 months of the 6-month period are separated from those of the last 3 months, the percentage of negative tests for the latter period is found to be 86 per cent.
DISCUSSION
As long ago as 1907 DeBlassi (6) claimed to have secured positive specific reactions in human malaria with an antigen prepared from Plasmodium vivax. The idea of utilizing a group reaction was introduced by Coggeshall and Eaton who demonstrated that an antigen from Plasmodium knowlesi could be used in studies of human malaria. Subsequently Kligler and Yoeli (7) using an antigen from Plasmodium gallinaceum found that it was nearly as effective as that attained with Plasmodium knoawlesi.
In our investigations, comparison of the number of positive tests in control sera with those of patients known to have had malaria showed that a group reaction could be obtained in sera from patients infected by Plasmodium vivax when an antigen prepared from Plasmodium gallinaceum was used. False positive tests reached as high a figure as 5 per cent in the group of syphilitic men studied, whereas it was under 1 per cent in normal healthy men. When the results on sera from the syphilitics are grouped with our other control data, the specificity of this test for malaria appears to be somewhat less than that of the various complement fixation tests for syphilis (8) , although obviously the procedures are not strictly comparable.
The sensitivity of the malaria complement fixation test was determined by dilution tests on strongly positive sera. At a dilution of 1: 5, only 40 per cent of the sera were still positive, and at a dilution of 1: 30, only 4 per cent were positive. It is impossible to compare these dilutionr tests accurately with complement fixation tests for syphilis because of differences in the character of the diseases and in the types of antigens. Nevertheless, it is of some interest that in dilution tests performed on 275 of the positive Wassermann tests in our control series of 481 syphilitic men, 55 per cent were positive at a dilution of 1 :60, 33 per cent at 1: 120, and 3 per cent at 1:600.
The results of the malaria complement fixation test during the 5-day period of the attacks were variable. It was possible for an individual to have negative tests throughout or in contrast to have positive tests on each of the 5 days. The number of previous attacks had no relationship to the subsequent serologic findings during a future attack. Comparison of 2 successive attacks showed that the results in each were frequently quite different and that the interval between attacks had no relation to the cQmplement fixation results during the attack.
In the interval between attacks, the test could not be used to predict that a recurrent attack would eventually appear or that a patient was cured. In a group of 300 attacks, it was found that the maximum number of positive tests occurred during the attack and that it decreased from 58 per cent to 33 per cent within 20 days. Five days prior to an attack, the percentage of positive tests was 34. In a very small series of 22 tests on the day before an attack and in 26 tests two days before an attack, only 14 and 23 per cent, respectively, were positive.
Over a 6-month period, the number of prior attacks and the total length of infection had no appreciable effect on the number of positive tests.
Whether the antibodies of immunity are those detected by this test is not known. The decline in percentage of positive tests following the attacks may conceivably be related to a fall or disappearance of sufficient available antibodies. This might then reflect the clinical evidence of lack of immunity as indicated by subsequent relapses. Such an impression would suggest that the plasmodia reside in reservoirs during the intervals between attacks at which time the circulating antibodies decline quantitatively, although some may be present at all times. However, it is also possible that the antibodies utilized in this test have no relation to the problem of immunity in this disease.
In.syphilis, a positive complement fixation test is usually obtained while the patient is still actively infected and this may cover a period of years but in the type of malaria studied in this investigation, an individual removed from an endemic area may still be actively infected as shown by subsequent relapses and yet intermittently have negative tests.
Successful application of a complement fixationtest in recurrent malaria depends both upon the specific properties of the antigen employed and the patient's antibody response to the disease. Factors which may have influenced the antibody response of these patients during the period in which these tests were performed were: (1) previous residence in endemic zones under more or less continuous suppressive treatment; (2) previous occurrence in most of the patients of multiple atta7cks of malaria due to infection with Plasmodium vivax and/or Plasmodium falciparum, with possible difference in strains within these species; (3) variation in length of time from original infection to the time of serological examination, with tendency toward a lower rate of attack with the passage of time; and (4) prompt initiation of therapy during the attacks under study with resultant disappearance of trophozoites from the blood.
